[go: up one dir, main page]

WO2009001019A3 - Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s) - Google Patents

Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s) Download PDF

Info

Publication number
WO2009001019A3
WO2009001019A3 PCT/FR2008/051042 FR2008051042W WO2009001019A3 WO 2009001019 A3 WO2009001019 A3 WO 2009001019A3 FR 2008051042 W FR2008051042 W FR 2008051042W WO 2009001019 A3 WO2009001019 A3 WO 2009001019A3
Authority
WO
WIPO (PCT)
Prior art keywords
water
nanocapsules
soluble
ingredient
core loaded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/051042
Other languages
English (en)
Other versions
WO2009001019A2 (fr
Inventor
Patrick Saulnier
Jean-Pierre Benoit
Nicolas Anton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAngers
Original Assignee
Universite dAngers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite dAngers filed Critical Universite dAngers
Priority to US12/663,937 priority Critical patent/US9333180B2/en
Priority to CA2690471A priority patent/CA2690471A1/fr
Priority to EP08805977A priority patent/EP2167053A2/fr
Publication of WO2009001019A2 publication Critical patent/WO2009001019A2/fr
Publication of WO2009001019A3 publication Critical patent/WO2009001019A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne des nanocapsules à cœur lipidique liquide et écorce lipidique solide et chargées au sein de leur cœur lipidique en au moins un actif hydrosoluble ou hydrodispersible, ledit actif y étant présent sous la forme d'un système micellaire inverse.
PCT/FR2008/051042 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s) Ceased WO2009001019A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/663,937 US9333180B2 (en) 2007-06-11 2008-06-11 Nanocapsules with a liquid lipid core charged with water-soluble or water-dispersible active agents
CA2690471A CA2690471A1 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
EP08805977A EP2167053A2 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755652A FR2916973B1 (fr) 2007-06-11 2007-06-11 Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
FR0755652 2007-06-11

Publications (2)

Publication Number Publication Date
WO2009001019A2 WO2009001019A2 (fr) 2008-12-31
WO2009001019A3 true WO2009001019A3 (fr) 2009-03-26

Family

ID=39046733

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051042 Ceased WO2009001019A2 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s)

Country Status (5)

Country Link
US (1) US9333180B2 (fr)
EP (1) EP2167053A2 (fr)
CA (1) CA2690471A1 (fr)
FR (1) FR2916973B1 (fr)
WO (1) WO2009001019A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393315B2 (en) 2011-06-08 2016-07-19 Nitto Denko Corporation Compounds for targeting drug delivery and enhancing siRNA activity
FR2939699B1 (fr) * 2008-12-12 2011-05-06 Univ Angers Procede de preparation de nanoparticules lipidiques
FR2943544B1 (fr) 2009-03-31 2012-04-20 Univ Angers Procede de preparation de capsules lipidiques fonctionnalisees.
US10196637B2 (en) 2011-06-08 2019-02-05 Nitto Denko Corporation Retinoid-lipid drug carrier
FR3017294B1 (fr) 2014-02-07 2021-10-01 Atlangram Nanoparticules lipidiques comprenant un antibiotique et leurs utilisations en therapie
WO2017005899A1 (fr) * 2015-07-09 2017-01-12 Medesis Pharma Préparation in situ de nanoparticules à pont cyano, à l'intérieur d'un système micellaire inverse biocompatible
WO2017153434A1 (fr) 2016-03-07 2017-09-14 Cryovac, Inc. Film à ouverture facile pour emballage moulant sous vide
GB201721832D0 (en) * 2017-12-22 2018-02-07 Waterford Institute Of Tech Ocular drug delivery
WO2020021052A2 (fr) 2018-07-27 2020-01-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation d'alcools terpéniques acycliques pour améliorer l'activité antimicrobienne de la colistine
EP3679928A1 (fr) 2019-01-08 2020-07-15 Atlangram Composition pharmaceutique de type gel pour traiter/prevenir une infection
US20220347111A1 (en) * 2019-06-21 2022-11-03 Université Catholique de Louvain Lipid nanocapsules charged with incretin mimetics
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805761A1 (fr) * 2000-03-02 2001-09-07 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
FR2840532B1 (fr) * 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
EP1955695A1 (fr) 2007-02-06 2008-08-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanocapsules de complexes lipophiles d'acides nucléiques
FR2916974B1 (fr) * 2007-06-11 2010-11-26 Univ Angers Procede de preparation de nanoparticules lipidiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805761A1 (fr) * 2000-03-02 2001-09-07 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2167053A2 *

Also Published As

Publication number Publication date
FR2916973A1 (fr) 2008-12-12
WO2009001019A2 (fr) 2008-12-31
CA2690471A1 (fr) 2008-12-31
FR2916973B1 (fr) 2010-02-26
EP2167053A2 (fr) 2010-03-31
US9333180B2 (en) 2016-05-10
US20100266676A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
WO2009001019A3 (fr) Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s)
WO2008089890A3 (fr) Concentré de suspension huileuse comprenant des substances actives agrochimiques micro-encapsulées
WO2007090393A3 (fr) Préparation pharmaceutique
WO2010031858A3 (fr) Rail de liaison pour éléments d'accumulateur et utilisation dudit rail
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2009043353A3 (fr) Oligonucléotides micromir
WO2009060097A3 (fr) Article hygiénique ou de soins contenant une quantité de polymères hydroactifs, et préparation présentant des bactériophages ou au moins un constituant de ces bactériophages
WO2008127784A3 (fr) Vêtements de protection avec systèmes d'ouverture rapide et procédés associés
WO2008128775A3 (fr) Composition pharmaceutique stabilisée contenant de la prégabaline
EP2447274A3 (fr) Composants oligomères et procédés
WO2010054154A3 (fr) Séquences crispr de bifidobactéries
WO2009062746A3 (fr) Médicaments topiques pour le traitement antimycotique
WO2008125091A3 (fr) Feuille métallique
WO2008025015A3 (fr) Échafaudages d'épitope et de transplant et leurs utilsation
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
WO2008027600A3 (fr) Compositions d'imatinib
PL2155688T3 (pl) Pochodne dinitropirazoli, ich wytwarzanie i kompozycje energetyczne je zawierające
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2009149058A8 (fr) Formulations de niacine à libération modifiée
WO2009135951A3 (fr) Procédé pour préparer un comprimé contenant de la metformine
WO2009124631A3 (fr) Préparation pour soins de jour
WO2008073863A3 (fr) Préparation et utilité d'allylamines substituées
ZA201009097B (en) C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter
WO2009103813A3 (fr) Compositions fongicides contenant du 3'-bromo-2,3,4,6'-tétraméthoxy-2'-6-diméthylbenzophénone
WO2010027590A3 (fr) Microreseaux en solution et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08805977

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008805977

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2690471

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12663937

Country of ref document: US